-
Nanotechnology is a broad field of research and development that is defined by its focus on the nanometer (nm) scale. This is generally agreed as covering items in the 1-100 nm range.
-
In a randomized placebo controlled trial, 55 adults with mild-to-moderate asthma were assigned 340 mg of daily oral magnesium citrate or a placebo for 6.5 months. Patients who received the Mg showed significant improvements in objective measures of bronchial reactivity to methacholine and peak expiratory flow rate and in subjective measures of asthma control and quality of life.
-
Integrated care consisting of a graded activity program and a workplace intervention was shown to reduce duration of time off work as a primary outcome, compared to usual care. Functional status in private life as a secondary outcome was also better in the integrated care group. Intensity of pain as a secondary outcome remained the same in both groups.
-
Middle-aged, postmenopausal women with significant symptomatic vasomotor events (VMEs) experienced equivalent significant relief of symptoms after 3 months of treatment with a flaxseed-enriched or an isocaloric control whole wheat- and barley-enriched diet. The VMEs in each group of recently menopausal patients were measured by a validated global scale, the Kupperman Menopausal Index, and a vasomotor diary at a Brazilian public health clinic over 12 weeks.
-
Fractures and bisphosphonate therapy, warfarin anticoagulation and influenza vaccine and cotrimoxazole, antiplatelet therapy with clopidogrel and aspirin, FDA Actions.
-
-
Piperacillin/Tazobactam (P/T) offers one of the broadest antimicrobial spectrums, and is equipped with an effective mechanism to maintain its potency in the presence of beta-lactamases.
-
These authors assessed the benefits of antiviral therapy of the index flu patient on reduced viral shedding and prevention of secondary household cases who did not receive chemoprophylaxis.
-
-
In this issue: Fractures and bisphosphonate therapy, warfarin anticoagulation and influenza vaccine and cotrimoxazole, antiplatelet therapy with clopidogrel and aspirin, FDA Actions.
